Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Norfolk, VA
NPI: 1467445999Primary Practice Location
SENTARA NORFOLK GENERAL HOSPITAL
600 Gresham Dr, Norfolk, VA
Primary Employer
Virginia Oncology Associates
virginiacancer.com
HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardVA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 539 | 2,023 |
| 2 | 80053Blood test, comprehensive group of blood chemicals | 518 | 1,660 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 447 | 784 |
| 4 | 36415Insertion of needle into vein for collection of blood sample | 402 | 997 |
| 5 | 86300Immunologic analysis for detection of tumor antigen | 319 | 776 |
Authors: Aditya Bardia, Kimberly Blackwell, Ayca Gucalp, Tiffany Traina, Haythem Ali
Journal: Breast Cancer Res Treat
Publication Date: 2018-05-09
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling.
Authors: Cynthia Osborne, Houston Holmes, Lea Krekow, Kristi Mcintyre, Joyce O'Shaughnessy, Joanne Blum
Publication Date: 2013-03-14
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.
Authors: Mansoor Saleh, Marcus Neubauer, Lee Schwartzberg, Richard Finn, Jennifer Specht, Joyce O'Shaughnessy, Paul Richards
Publication Date: 2014-10-29
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: placebo, DRUG: nab-paclitaxel, DRUG: alpelisib
Lead Sponsor: G1 Therapeutics, Inc.
Intervention / Treatment: DRUG: Trilaciclib, DRUG: Sacituzumab Govitecan-hziy
Lead Sponsor: Ambrx, Inc.
Intervention / Treatment: DRUG: ARX788
